Christer Dahlstrand

Learn More
OBJECTIVE To report an integrated analysis of two previous studies fully characterizing the clinical utility of the controlled-release gastrointestinal therapeutic system (GITS) formulation of doxazosin in the treatment of benign prostatic hyperplasia (BPH). PATIENTS AND METHODS Two pivotal randomized, double-blind studies of doxazosin GITS for BPH were(More)
OBJECTIVES To estimate the relationship between age and the values of different diagnostic tests in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic enlargement (BPE) and to compare prostate growth curves between the normal population sample, healthy men and men with LUTS. MATERIAL AND METHODS A series of 354 men (mean age 70.2(More)
OBJECTIVES To detect obstruction in patients with LUTS suggestive of BPH comparing the prostatic intravesical protrusion detected by abdominal ultrasounds with uroflowmetry testing results with urodynamic study to make evidence of obstruction. MATERIAL AND METHODS A series of 25 patients (mean age 67.9 years) at the first visit for BPH problems, underwent(More)
BACKGROUND The alpha(1)-blocker doxazosin mesylate is an established efficacious and welltolerated treatment for benign prostatic hyperplasia (PBH). However, its clinical utility can be limited by the need for multiple titration steps, starting at an initial dose of 1 mg, increased up to 8 mg once daily, to achieve optimal therapeutic response. A new(More)
OBJECTIVES To assess the precision of five different calculation methods in real-time bladder volume measurement. MATERIAL AND METHODS Bladders from 10 medical staff volunteers were examined. Two examinations of each subject were performed by one examiner using the same ultrasound scannet Five different calculation algorithms were used on the frozen(More)
INTRODUCTION PRIMARY OBJECTIVE to investigate if 30-MINUTES-TUMT can be performed under topical anesthesia and analgesics. SECONDARY OBJECTIVES to evaluate retrospectively analgesics and to study parameters connected with pain. MATERIALS AND METHODS Eighty-nine patients underwent TUMT. Patients were divided into four groups with different(More)
OBJECTIVE For patients with the combination of severe bladder outlet obstruction (BOO) and severe overactive bladder (OB), no straightforward and safe treatment exists due to the risk of urge incontinence after TURP. In this study we have used a biodegradable polyglycolic stent to simulate the status after TURP and register the risk for urge incontinence.(More)
PURPOSE To evaluate the durability of the effect of transurethral microwave thermotherapy (TUMT) for lower urinary-tract symptoms (LUTS) suggestive of bladder outlet obstruction (BOO). PATIENTS AND METHODS A total of 841 patients with LUTS received TUMT using the Prostatron device at Sahlgrenska University Hospital, Sweden. Two treatment programs were(More)
To assess the durability of the results of transurethral microwave thermotherapy (TUMT) for symptomatic benign prostatic hyperplasia (BPH), we have reviewed publications describing trials with at least 3 years of follow-up. For men treated only by TUMT, improvement in symptoms and quality of life appears to be maintained for at least 4 to 5 years.(More)
The objective of this study was to assess the use of temporary stenting of the prostatic urethra for the prevention of acute rinary retention after high-energy transurethral microwave thermotherapy (TUMT) of the prostate. Stenting was performed immediately after high-energy microwave therapy. Two stents were used at two sites; at one site a silicone(More)